Integra Lifesciences Holdings (IART) Net Cash Flow (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Net Cash Flow of -$21.3 million for Q2 2026, down 754.95% sequentially from $3.3 million in Q1 2026, and up 37.11% YoY from -$15.5 million in Q2 2025.
Integra Lifesciences Holdings (IART) Net Cash Flow (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Net Cash Flow for 18 years, with the latest figure at -$21.3 million in Q2 2026.
- Quarterly Net Cash Flow rose 37.11% year-over-year to -$21.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.7 million (up 87.83% YoY) and the FY2025 annual result came in at -$29.3 million, down 24.53% from the prior year.
- Net Cash Flow eased to -$21.3 million in Q2 2026 per IART's latest filing, from $3.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $320.5 million in Q1 2024 and troughed at -$375.5 million in Q2 2024.
- A 5-year average of -$16.7 million and a median of -$6.6 million in 2023 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 832.74% in 2024, down 18527.13% in 2024.
- Over 5 years, Net Cash Flow stood at -$67.2 million in 2022, then jumped by 92.01% to -$5.4 million in 2023, then jumped by 832.74% to $39.3 million in 2024, then sank by 96.82% to $1.3 million in 2025, then sank by 1802.56% to -$21.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$21.3 million, $3.3 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | -21.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.30 Mn |
| Jun 30, 2026 | -21.30 Mn |
| Mar 31, 2026 | 3.25 Mn |
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 15.07 Mn |
| Sep 30, 2025 | 15.07 Mn |
| Jun 30, 2025 | -33.87 Mn |
| Jun 30, 2025 | -33.87 Mn |
| Mar 31, 2025 | -11.80 Mn |
| Mar 31, 2025 | -11.80 Mn |
| Dec 31, 2024 | 39.34 Mn |
| Dec 31, 2024 | 39.34 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Jun 30, 2024 | -375.55 Mn |
| Jun 30, 2024 | -375.55 Mn |
| Mar 31, 2024 | 320.47 Mn |
| Mar 31, 2024 | 320.47 Mn |